SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
progenics
An SI Board Since January 1998
Posts SubjectMarks Bans Symbol
139 21 0 PGNX
Emcee:  William Nelson Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
114<Causing another reiteration by Aschoff.> Me and Aschoff are buddies. Thkenhott-5/23/2008
113Causing another reiteration by Aschoff. Stock price get hammered as this POI retuck-5/23/2008
112Bombed POI, hit on oral. ------------------------- Wyeth and Progenics Announcekenhott-5/22/2008
111<reply> Here is what you are looking for: www.medicare.gov/publications/kenhott-5/9/2008
110<reply> Too much babble but last bit. I see now you are a fan of Adam? kenhott-5/1/2008
109<reply> Ya, too much spam. Funny but I actually like Spam. Re: oral, mykenhott-4/29/2008
108<reply> I saw that too and I thought it was a little strange. But I am nkenhott-4/28/2008
107Progenics Pharmaceuticals (PGNX) PGNX March volatility at 179 into PDUFA. PGNX Esoteric1-4/25/2008
106Stifel Nicolaus Says Pullback on Progenics Pharma (PGNX) is Buying Opportunity MEsoteric1-4/25/2008
105Broadpoint today says AMI alone is worth $15/share. Keeps $30 target price 3Esoteric1-4/25/2008
1049-27-07 analyst Jonathan Aschoff of Brean Murray maintains his "buy" rEsoteric1-4/25/2008
1039-20-2007 analysts at Lazard Capital maintain their "buy" rating on PrEsoteric1-4/25/2008
102>>Progenics and Wyeth Announce FDA Has Approved RELISTOR Thursday April 24tuck-4/25/2008
101Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOkenhott-4/24/2008
100>>Wyeth and Progenics Announce RELISTOR Receives Canadian Marketing Approvtuck-4/1/2008
99I think some people are thinking they are pretty smart about what they know aboukenhott-3/27/2008
98Does anyone here have a position in PGNX? Maybe this article explains why the shejgopher-3/26/2008
97I am not sure one can call something an investment if one only had it for less tkenhott-3/13/2008
96Wasn't dissing the investment. I've long pulled for 140.keokalani'nui-3/12/2008
95<what kind of hernia repair today needs even an overnight stay?> The kindkenhott-3/12/2008
94Company calls it "the methylnaltrexone franchise"? That's some sekeokalani'nui-3/12/2008
93This failed phase 3 involved changing around the plumbing + ileus disease complekenhott-3/12/2008
92POI seems to be a tough indication! Have you (or anyone) figured odds on the SCtuck-3/12/2008
91Wyeth and Progenics Provide Update on Phase 3 Clinical Trial of Intravenous Methkenhott-3/12/2008
90On the other hand, if the QT data is benign, it derisks the application & oftuck-1/10/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):